TY - JOUR
T1 - Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspring
AU - Cicero, T. J.
AU - Adams, M. L.
AU - Giordano, A.
AU - Miller, B. T.
AU - O'Connor, L.
AU - Nock, B.
PY - 1991
Y1 - 1991
N2 - The effects of adolescent morphine exposure on the sexual maturation of male rats, their reproductive capacity and the development of their progeny were examined. Groups of prepubescent male rates (25-27 days of age) were implanted with morphine- or placebo-pellets (one on Day 1, then two pellets on Days 4, 7 and 10); the pellets were not removed to assure the sustained release of morphine for 3 to 4 weeks and to avoid the confounding effects of a precipitated withdrawal syndrome. Groups of animals were sacrificed at weekly intervals through adulthood for an assessment of reproductive endocrine function. A large group, however, was also bred with drug-naive primiparous females at 85 days of age (8 weeks after morphine or placebo pellet implantation), when the acute and chronic effects of morphine on reproductive endocrine parameters had dissipated; their fertility and the development of the male and female progeny was characterized. Our results indicated that morphine exposure during adolescence led to a pronounced inhibition of a number of indices of sexual maturation (e.g., serum testosterone and luteinizing hormone levels and reduced weights of the testes and seminal vesicles). Breeding morphine- and placebo-implanted male rats with drug-naive females resulted in smaller liters derived from morphine-treated fathers when compared to controls, but in all other respects the development of the offspring in the two groups were equivalent. However, upon reaching adulthood, a number of selective endocrine differences were detected in morphine-derived offspring when compared to controls. Adult male offspring of morphine-treated males had significantly lower serum testosterone and luteinizing hormone levels. Hypothalamic β-endorphin levels were modestly elevated in male adult morphine-derived offspring, but these differences were not statistically significant. Adrenal weights were also significantly higher in morphine-derived male offspring, but serum corticosterone levels were within the normal range. A somewhat different pattern of endocrine deficits was observed in adult female morphine-derived offspring. Large increases in serum corticosterone levels were observed in female morphine-derived offspring and, in addition, β-endorphin levels in the hypothalamus were also significantly higher. In contrast to the male, no differences in reproductive endocrine status were observed in adult female morphine-derived offspring. Our data suggest that a period of exposure to opiates during adolescence cannot only influence markedly sexual maturation, but can also have long-term, selective and gender specific effects on endocrine function in their offspring.
AB - The effects of adolescent morphine exposure on the sexual maturation of male rats, their reproductive capacity and the development of their progeny were examined. Groups of prepubescent male rates (25-27 days of age) were implanted with morphine- or placebo-pellets (one on Day 1, then two pellets on Days 4, 7 and 10); the pellets were not removed to assure the sustained release of morphine for 3 to 4 weeks and to avoid the confounding effects of a precipitated withdrawal syndrome. Groups of animals were sacrificed at weekly intervals through adulthood for an assessment of reproductive endocrine function. A large group, however, was also bred with drug-naive primiparous females at 85 days of age (8 weeks after morphine or placebo pellet implantation), when the acute and chronic effects of morphine on reproductive endocrine parameters had dissipated; their fertility and the development of the male and female progeny was characterized. Our results indicated that morphine exposure during adolescence led to a pronounced inhibition of a number of indices of sexual maturation (e.g., serum testosterone and luteinizing hormone levels and reduced weights of the testes and seminal vesicles). Breeding morphine- and placebo-implanted male rats with drug-naive females resulted in smaller liters derived from morphine-treated fathers when compared to controls, but in all other respects the development of the offspring in the two groups were equivalent. However, upon reaching adulthood, a number of selective endocrine differences were detected in morphine-derived offspring when compared to controls. Adult male offspring of morphine-treated males had significantly lower serum testosterone and luteinizing hormone levels. Hypothalamic β-endorphin levels were modestly elevated in male adult morphine-derived offspring, but these differences were not statistically significant. Adrenal weights were also significantly higher in morphine-derived male offspring, but serum corticosterone levels were within the normal range. A somewhat different pattern of endocrine deficits was observed in adult female morphine-derived offspring. Large increases in serum corticosterone levels were observed in female morphine-derived offspring and, in addition, β-endorphin levels in the hypothalamus were also significantly higher. In contrast to the male, no differences in reproductive endocrine status were observed in adult female morphine-derived offspring. Our data suggest that a period of exposure to opiates during adolescence cannot only influence markedly sexual maturation, but can also have long-term, selective and gender specific effects on endocrine function in their offspring.
UR - http://www.scopus.com/inward/record.url?scp=0025904596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025904596&partnerID=8YFLogxK
M3 - Article
C2 - 2005573
AN - SCOPUS:0025904596
SN - 0022-3565
VL - 256
SP - 1086
EP - 1093
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 3
ER -